We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more
Govorestat NDA for Classic Galactosemia under Priority Review, PDUFA target action date of November 28, 2024 Govorestat MAA under review by EMA; Day 120 3-month clock-stop extension granted;...
NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.24 | -5.18358531317 | 4.63 | 4.88 | 4.345 | 442455 | 4.7410387 | CS |
4 | -0.93 | -17.4812030075 | 5.32 | 5.41 | 4.165 | 705256 | 4.59973932 | CS |
12 | 0.64 | 17.0666666667 | 3.75 | 9.39 | 3.73 | 1680688 | 5.96195495 | CS |
26 | 2.31 | 111.057692308 | 2.08 | 9.39 | 1.79 | 1588177 | 4.37290107 | CS |
52 | 2.68 | 156.725146199 | 1.71 | 9.39 | 1.18 | 1079708 | 3.73760678 | CS |
156 | -12.96 | -74.6974063401 | 17.35 | 25.59 | 0.4995 | 547558 | 3.57202581 | CS |
260 | -3.65 | -45.3980099502 | 8.04 | 57.39 | 0.4995 | 383579 | 7.36511897 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions